Impact of gene therapy for canine monogenic diseases on the progress of preclinical studies.

Abstract excerpt

Rapid progress in knowledge of the organization of the dog genome has facilitated the identification of the mutations responsible for numerous monogenic diseases, which usually present a breed-specific distribution. The majority of these diseases have clinical and molecular counterparts in humans. The affected dogs have thus become valuable models for preclinical studies of gene therapy for problems such as eye...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Dog Diseases
• Share to Eye Diseases
• Share to Genetic Diseases, Inborn